Protection of hemopoietic cells during chemotherapy or radiotherapy
Patent Number: 5595973
Date of First Priority Issue: Wednesday September 21st, 1994
Date Issued: Tuesday January 21st, 1997
Assignee: Biomeasure Incorporated (Milford, MA)
Inventor: Bogden, Arthur E. (Hopedale, MA)
From Class: Expansion
Comments: No comments
This patent is useful in the treatment of patients with radiation or chemotherapy. Since hematopoietic stem cell toxicity is usually the dose limiting factor in radiation or chemotherapy, this patent teaches a way how to overcome this.
Specifically, the patent claims inhibiting hematopoietic stem cell proliferation through administration of AcSDKP, then providing the chemotherapy and/or radiation therapy, followed by administration of a stem cell stimulator.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.